• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immune-related eosinophilia induced by anti-programmed death 1 or death-ligand 1 antibodies.

作者信息

Bernard-Tessier Alice, Jeanville Priscilla, Champiat Stéphane, Lazarovici Julien, Voisin Anne-Laure, Mateus Christine, Lambotte Olivier, Annereau Maxime, Michot Jean-Marie

机构信息

Drug Development Department, Université Paris-Saclay, Villejuif, F-94805, France.

Pharmacy Department, Université Paris-Saclay, Villejuif, F-94805, France.

出版信息

Eur J Cancer. 2017 Aug;81:135-137. doi: 10.1016/j.ejca.2017.05.017.

DOI:10.1016/j.ejca.2017.05.017
PMID:28624693
Abstract
摘要

相似文献

1
Immune-related eosinophilia induced by anti-programmed death 1 or death-ligand 1 antibodies.抗程序性死亡1或死亡配体1抗体诱导的免疫相关嗜酸性粒细胞增多症。
Eur J Cancer. 2017 Aug;81:135-137. doi: 10.1016/j.ejca.2017.05.017.
2
Immune checkpoint inhibitors in lung cancer: an update.肺癌中的免疫检查点抑制剂：最新进展
Future Oncol. 2017 May;13(11):955-959. doi: 10.2217/fon-2017-0044.
3
Bullous pemphigoid, an autoantibody-mediated disease, is a novel immune-related adverse event in patients treated with anti-programmed cell death 1 antibodies.大疱性类天疱疮是一种自身抗体介导的疾病，是接受抗程序性细胞死亡蛋白1抗体治疗的患者中出现的一种新型免疫相关不良事件。
Melanoma Res. 2016 Aug;26(4):413-6. doi: 10.1097/CMR.0000000000000260.
4
Atypical severe immune-related adverse effects resulting from sequenced immunotherapy in melanoma.黑色素瘤序贯免疫治疗导致的非典型严重免疫相关不良反应。
Melanoma Res. 2015 Apr;25(2):178-9. doi: 10.1097/CMR.0000000000000132.
5
Managing adverse effects of immunotherapy.免疫疗法不良反应的管理。
Clin Adv Hematol Oncol. 2018 May;16(5):364-374.
6
Unresectable Non-metastatic Primary Melanoma: Complete Remission Following Treatment with Anti-Programmed-cell-death-receptor 1.不可切除的非转移性原发性黑色素瘤：抗程序性细胞死亡受体1治疗后完全缓解
Acta Derm Venereol. 2019 Jan 1;99(1):107-108. doi: 10.2340/00015555-3028.
7
Immune checkpoint inhibitor-associated hypophysitis-World Health Organisation VigiBase report analysis.免疫检查点抑制剂相关垂体炎——世界卫生组织药物不良反应数据库报告分析
Eur J Cancer. 2019 May;113:10-13. doi: 10.1016/j.ejca.2019.03.002. Epub 2019 Apr 4.
8
PD-1 Antibody-induced Guillain-Barré Syndrome in a Patient with Metastatic Melanoma.一名转移性黑色素瘤患者发生的PD-1抗体诱导的吉兰-巴雷综合征
Acta Derm Venereol. 2017 Mar 10;97(3):395-396. doi: 10.2340/00015555-2548.
9
Blood Assay Predicts Response to Pembrolizumab.血液检测预测对帕博利珠单抗的反应。
Cancer Discov. 2016 Nov;6(11):1200. doi: 10.1158/2159-8290.CD-NB2016-122. Epub 2016 Oct 3.
10
Nivolumab and pembrolizumab as immune-modulating monoclonal antibodies targeting the PD-1 receptor to treat melanoma.纳武单抗和派姆单抗作为靶向程序性死亡受体1（PD-1）受体的免疫调节单克隆抗体用于治疗黑色素瘤。
Expert Rev Anticancer Ther. 2015;15(9):981-93. doi: 10.1586/14737140.2015.1074862. Epub 2015 Jul 30.

引用本文的文献

1
The Role of Eosinophils, Eosinophil-Related Cytokines and AI in Predicting Immunotherapy Efficacy in NSCLC Cancer.嗜酸性粒细胞、嗜酸性粒细胞相关细胞因子及人工智能在预测非小细胞肺癌免疫治疗疗效中的作用
Biomolecules. 2025 Mar 27;15(4):491. doi: 10.3390/biom15040491.
2
Exploring the Dynamics of Immune Checkpoint Inhibitor-Induced Eosinophilia in Advanced/Metastatic Melanoma: A Comprehensive Retrospective Analysis.探索晚期/转移性黑色素瘤中免疫检查点抑制剂诱导的嗜酸性粒细胞增多症的动态变化：一项全面的回顾性分析。
Cancer Med. 2025 Apr;14(7):e70679. doi: 10.1002/cam4.70679.
3
The ascendancy of eosinophil counts in non-small cell lung cancer: a potential marker for predicting response and survival under nivolumab treatment.
非小细胞肺癌中嗜酸性粒细胞计数的优势：一种预测纳武单抗治疗反应和生存的潜在标志物。
Am J Cancer Res. 2024 Oct 25;14(10):5095-5104. doi: 10.62347/KRTH2276. eCollection 2024.
4
Complete response to fifth-line anti-PD-1 rechallenge in fumarate hydratase-mutated papillary renal cell carcinoma.富马酸水合酶突变型乳头状肾细胞癌对第五线抗程序性死亡蛋白1再激发治疗的完全缓解
NPJ Precis Oncol. 2024 Nov 4;8(1):251. doi: 10.1038/s41698-024-00750-3.
5
Targeted inhibition of the IL5 axis for immune checkpoint inhibitors eosinophilic-induced adverse events.针对免疫检查点抑制剂诱导的嗜酸性粒细胞不良事件中 IL5 轴的靶向抑制。
J Immunother Cancer. 2024 Oct 12;12(10):e009658. doi: 10.1136/jitc-2024-009658.
6
Review of T Helper 2-Type Inflammatory Diseases Following Immune Checkpoint Inhibitor Treatment.免疫检查点抑制剂治疗后2型辅助性T细胞炎症性疾病的综述
Biomedicines. 2024 Aug 19;12(8):1886. doi: 10.3390/biomedicines12081886.
7
Acute Eosinophilic Pneumonia Induced by Immune Checkpoint Inhibitor and Anti-TIGIT Therapy.免疫检查点抑制剂和抗 TIGIT 治疗引起的急性嗜酸性肺炎。
Am J Case Rep. 2024 Jul 6;25:e943740. doi: 10.12659/AJCR.943740.
8
Eosinophilic granulocytes as a potential prognostic marker for cancer progression and therapeutic response in malignant melanoma.嗜酸性粒细胞作为恶性黑色素瘤癌症进展和治疗反应的潜在预后标志物。
Front Oncol. 2024 May 2;14:1366081. doi: 10.3389/fonc.2024.1366081. eCollection 2024.
9
Pembrolizumab-induced asthma exacerbation with hypereosinophilia and elevated interleukin-5 in endometrial cancer: A case report.帕博利珠单抗诱发子宫内膜癌患者哮喘加重伴嗜酸性粒细胞增多和白细胞介素-5升高：一例报告
Respir Med Case Rep. 2024 Apr 30;49:102035. doi: 10.1016/j.rmcr.2024.102035. eCollection 2024.
10
Role of eosinophilia in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab: Prediction of immune-related adverse events and favorable outcome.尼伏单抗治疗复发性/转移性头颈部鳞状细胞癌患者中嗜酸性粒细胞的作用：预测免疫相关不良事件和良好结局。
Cancer Med. 2023 Nov;12(22):20810-20820. doi: 10.1002/cam4.6648. Epub 2023 Oct 30.